A woman with hypothyroidism is switched from levothyroxine to liothyronine. Which major pharmacologic difference should the physician consider?
Show answer and explanation
Correct answer: Shorter half-life of liothyronine
Liothyronine (T3) has a shorter half-life and greater potency, increasing the risk of adverse cardiovascular effects.
Keep practicing
More Endocrine pharmacotherapy questions
- A diabetic patient begins therapy with a sulfonylurea. Which adverse effect is the patient most at risk for?
- A patient with type 2 diabetes is started on a GLP-1 analog such as liraglutide. Which additional benefit is expected?
- A patient with Cushing syndrome undergoes medical therapy before surgery. Which drug inhibits 11β-hydroxylase?
- A patient with osteoporosis is started on alendronate. Which adverse effect should be emphasized?
- A woman with acromegaly is prescribed octreotide. Which hormone does this drug primarily inhibit?
- A patient on an SGLT2 inhibitor such as canagliflozin should be monitored for which adverse effect?